Vitamin D Toxicity Symptoms
XGEVA ® (denosumab) approval in the European Union, Thousand Oaks, California, 15 July 2011 / PRNewswire / – Amgen (NASDAQ: AMGN) today announced that the European Commission (EC) has received approval for XGEVA ® (denosumab) for the prevention of skeletal related events (SRE) (pathological fractures, Radiation given bone, spinal cord compression or surgery to bone) [...]